"Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers"

Hwang K, Yoon JH, Lee JH, Lee S., Biomedicines, doi: 10.3390/biomedicines9010039, 1

"Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy"

Kim JW, Cho YB, Lee S, Cells, doi: 10.3390/cells10030670, 3

"TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy"

Heo K, Lee S, Biomolecules, pii: E388, doi: 10.3390/biom10030388, 3

"Humanized Anti-hepatocyte Growth Factor Monoclonal Antibody (YYB-101) Inhibits Ovarian Cancer Progression"

Kim HJ, Lee S, Oh YS, Chang HK, Kim YS, Hong SH, Kim JY, Park YW, Lee SJ, Song SW, Kim JJ, Heo K, Frontiers in Oncology, doi: 10.3389/fonc.2019.00571, 571

"Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth."

Jeoung MH, Kim TK, Kim JW, Cho YB, Na HJ, Yoo BC, Shim H, Song DK, Heo K, Lee S, Biomolecules, pii: E681, doi: 10.3390/biom9110681, 11

"Ultrasensitive NIR-SERRS Probes with Multiplexed Ratiometric Quantification for In Vivo Antibody Leads Validation"

Kang H, Jeong S, Jo A, Chang H, Yang JK, Jeong C, Kyeong S, Lee YW, Samanta A, Maiti KK, Cha MG, Kim TK, Lee S, Jun BH, Chang YT, Chung J, Lee HY, Jeong DH, Lee YS., Advanced Healthcare Materials, doi: 10.1002/adhm.201700870., 4

"Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a"

Kim TK, Park CS, Jang J, Kim MR, Na HJ, Lee K, Kim HJ, Heo K, Yoo BC, Kim YM, Lee JW, Kim SJ, Kim ES, Kim DY, Cha K, Lee TG, Lee S, Molecular Oncology, doi: 10.1002/1878-0261.12169., 3

"Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer"

Kong DH, Kim YK, Kim MR, Jang JH, Lee S, International Journal of Molecular Sciences, pii: E1057., doi: 10.3390/ijms19041057, 4